ArticleAnnals of internal medicine2023

In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin.

Krysta Brown et al.PubMed ↗Publisher ↗

No numbers read from the abstract.